Immuno-Onoclogy Summit 2022 Posters

October 17, 2022

Immuno-Onoclogy Summit 2022 Posters

Check out the latest data on patient-derived organoids for immunotherapy development

read more

ELRIG 2022 Posters

October 11, 2022

ELRIG 2022 Posters

Check out the latest data on patient-derived organoids that HUB presented at ELRIG drug discovery meeting in 2022.

read more

Human liver patient-derived HUB Organoids as a promising tool to study drug-induced liver injury and drug metabolism for improved preclinical toxicology assessment

October 6, 2022

Human liver patient-derived HUB Organoids as a promising tool to study drug-induced liver injury and drug metabolism for improved preclinical toxicology assessment

Drug toxicology studies are essential for assessing drug safety and represent a pivotal step in the preclinical stages of drug development.

read more

Patient-derived organoids as a model for treatment diagnosis in Cystic Fibrosis – combinatory treatment with read-through agent, correctors and potentiator on rare mutations

July 6, 2022

Patient-derived organoids as a model for treatment diagnosis in Cystic Fibrosis – combinatory treatment with read-through agent, correctors and potentiator on rare mutations

Cystic fibrosis (CF) patient prognosis has recently improved due to the development of new, more effective treatments and better combination strategies for...

read more

Patient in the lab: predicting clinical responses using patient-derived organoid screening

June 3, 2022

Patient in the lab: predicting clinical responses using patient-derived organoid screening

Adult epithelial stem cell-derived organoids (HUB Organoids™) are proving to be a major breakthrough in preclinical models. HUB Organoids are fundamentally changing...

read more

Patient-derived organoids predict clinical response: a patient in the lab

June 3, 2022

Patient-derived organoids predict clinical response: a patient in the lab

Colorectal cancer (CRC) is the third leading cause of cancer and cancer-related death. A large fraction of the CRC patients diagnosed with...

read more

Application of HUB Organoids® to Immunotherapy development

June 3, 2022

Application of HUB Organoids® to Immunotherapy development

Poster P03: Autologous organoid and T cell co-cultures as a powerful personalized platform for Immunotherapy development

read more

EUROTOX 2021 | Poster 391

February 17, 2022

EUROTOX 2021 | Poster 391

Discover how to reduce costly animal experiments and obtain a quick indication of your drug safety with Merel Derksen. Poster 391: Intestinal organoids as in vitro model...

read more

EUROTOX 2021 | Poster 553

February 17, 2022

EUROTOX 2021 | Poster 553

Dr. Pourfarzad presents data on the use of HUB Organoids as advanced modes to investigate ADME and safety. Poster 553: HUB Organoids™ improve preclinical toxicology, metabolism, and...

read more

X

Have any questions?

contact us